stockrowArcutis Biotherapeutics, Inc.
ARQT Healthcare Biotechnology
Arcutis Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 91.3% from fiscal 2024.
- Revenue
- +45.1%
- EPS
- +12.0%
- Free cash flow
- +1,171.9%
- Total debt
- +0.83%
Quarter to September 2026, against a year earlier
Follow ARQT
Alert me
Arcutis Biotherapeutics, Inc. (ARQT) Operating margin
Arcutis Biotherapeutics, Inc.'s operating margin over the twelve months to 30 September 2026 was 6.91%, up 10.2 percentage points from fiscal 2025 (−3.25%). Over the past ten years it has ranged from −8,183.0% (fiscal 2022) to 0.00% (fiscal 2021); the current reading is higher than 44% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −3.25% | 62.08 |
| FY2024 | −65.3% | 339.16 |
| FY2023 | −404.5% | 7,778.55 |
| FY2022 | −8,183.0% | (8,183.04) |
| FY2021 | 0.00% | 0.00 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 6.56% | (6.09) |
| Jun 2026 | 12.7% | 21.27 |
| Mar 2026 | −8.62% | (22.82) |
| Dec 2025 | 14.2% | 5.61 |
| 27 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ARQT Arcutis Biotherapeutics, Inc. | 6.91% |
| EWTX Edgewise Therapeutics, Inc. compare | 0.00% |
| TNGX Tango Therapeutics, Inc. compare | 0.00% |
| DFTX Definium Therapeutics, Inc. compare | 0.00% |
| LEGN Legend Biotech Corporation Sponsored ADR compare | −5.06% |
| IOVA Iovance Biotherapeutics, Inc. compare | −60.8% |
| ABCL AbCellera Biologics Inc. compare | −340.3% |
| RLAY Relay Therapeutics, Inc. compare | −2,815.5% |
| DNTH Dianthus Therapeutics, Inc. compare | −8,683.9% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ARQT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Altman Z-score
- Beneish M-score
- The full statement